Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the clinical classification
Authors:
- Jose V. BaganJBJose V. Bagan
- Yolanda JimenezYJYolanda Jimenez
- Jose M. DiazJDJose M. Diaz
- Judith MurilloJMJudith Murillo
- Jose M. SanchisJSJose M. Sanchis
- Rafael PovedaRPRafael Poveda
- Enrique CarbonellECEnrique Carbonell
- Carmen GavaldaCGCarmen Gavalda
- Crispian ScullyCSCrispian Scully
- 1 July 2009
- journal article
- other
- Published by Elsevier in Oral Oncology
- Vol. 45 (7) , 645-646
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Early Surgical Approach Preferable to Medical Therapy for Bisphosphonate-Related Osteonecrosis of the JawsJournal of Oral and Maxillofacial Surgery, 2008
- Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and TreatmentJournal of Oral and Maxillofacial Surgery, 2007
- Surgical Therapy for Osteonecotic Lesions of the Jaws in Patients in Therapy With BisphosphonatesJournal of Craniofacial Surgery, 2007
- Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and managementOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 casesOral Oncology, 2006
- Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 casesJournal of Oral Pathology & Medicine, 2005
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003